Hepatitis C, Chronic Clinical Trials Database - Free Access to 281 Studies
Access comprehensive clinical trial information for Hepatitis C, Chronic through Pure Global AI's free database. This collection includes 281 clinical trials across multiple phases including Phase 2, N/A, Phase 4. Currently, 6 trials are actively recruiting participants.
Research for Hepatitis C, Chronic is being conducted in United States of America, Puerto Rico,United States of America, Japan and 7+ other countries. Leading sponsors include Hoffmann-La Roche and Merck Sharp & Dohme LLC. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children
Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals
Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C
Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs
The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic HCV Genotype 2 Infection
HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels
A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe Programs
Rapid HCV RNA Testing and LInkage to Care
Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir
Voices From the Black Community: Hepatitis C Research Participation
SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C
Re-engaging Patients With Hepatitis C Into Care
KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C
The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study
Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera
Evaluation of Dried Blood Spot for HCV RNA Testing
Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Villages
Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3)
Hepatitis C Surveillance With Linkage to Care of Patients From Non-ID Departments in Jiangsu
Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting
Pure Global AI provides free access to 281 clinical trials studying Hepatitis C, Chronic, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Hoffmann-La Roche, Merck Sharp & Dohme LLC, Boehringer Ingelheim, among others.